United States - English - NLM (National Library of Medicine)

fresenius medical care north america - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 900 mg in 100 ml - intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient. none known.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient. none known. check flexible container solution composition, lot number, and expiry date. do not remove solution container from its overwrap until immediately before use. use sterile equipment and aseptic technique. to open - turn solution container over so that the text is face down. using the pre-cut corner tabs, peel open the overwrap and remove solution container. - check the solution container for leaks by squeezing firmly. if leaks are found, or if the seal is not intact, discard the solution. - do not use if the solution is cloudy or a precipitate is present. to add medication - identify white additive port with arrow pointing toward container. - immediately before injecting additives, break off white additive port cap with the arrow pointing toward container. - hold base of white additive port horizontally. - insert needle horizont

United States - English - NLM (National Library of Medicine)

braintree laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium sulfate anhydrous (unii: ml30mj2u7i) (magnesium cation - unii:t6v3lhy838), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698) - suflave is indicated for the cleansing of the colon as a preparation for colonoscopy in adults. suflave is contraindicated in the following conditions: - gastrointestinal obstruction or ileus [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precautions ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any ingredient in suflave  [see warnings and precautions ( 5.8)] risk summary there are no available data on the use of suflave during pregnancy to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride (suflave). the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other ad

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (chloride ion - unii:q32zn48698, potassium cation - unii:295o53k152) - sodium chloride 0.86 g in 100 ml - this solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. the use of ringer’s injection usp is contraindicated in neonates (28 days of age or younger) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream [see warnings, drug interactions, pediatric use ]. this solution is contraindicated where the administration of sodium, potassium, calcium, or chloride could be clinically detrimental.

United States - English - NLM (National Library of Medicine)

gm scientific, llc - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37) - sodium chloride 600 mg in 100 ml - gms electrolyte solution compound sodium lactate (hartmann’s solution) is indicated as a source of water and electrolytes for all species. it is also used as an alkalinizing agent. gms electrolyte solution compound sodium lactate (hartmann’s solution) is contraindicated in patients with a known hypersensitivity to sodium lactate; congestive heart failure or severe impairment of renal function; clinical states in which the administration of sodium and chloride is detrimental.

United States - English - NLM (National Library of Medicine)

it3 medical llc - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb) - lactated ringer’s injection, usp is indicated as a source of water and electrolytes or as an alkalinizing agent. as for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and lactated ringer’s injection, usp is contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream). in patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including lactated ringer’s injection, usp, through the same infusion line (e.g., via y-connector). if the same infusion line is used for sequential administration, the line must be thoroughly flushed between infusions with a compatible fluid. lactated ringer’s injection, usp is contraindicated in patients with a known hypersensitivity to sodium lactate.

United States - English - NLM (National Library of Medicine)

it3 medical llc - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb) - lactated ringer’s injection, usp is indicated as a source of water and electrolytes or as an alkalinizing agent. as for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and lactated ringer’s injection, usp is contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream). in patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including lactated ringer’s injection, usp, through the same infusion line (e.g., via y-connector). if the same infusion line is used for sequential administration, the line must be thoroughly flushed between infusions with a compatible fluid. lactated ringer’s injection, usp is contraindicated in patients with a known hypersensitivity to sodium lactate.

United States - English - NLM (National Library of Medicine)

it3 medical llc - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb) - lactated ringer’s injection, usp is indicated as a source of water and electrolytes or as an alkalinizing agent. as for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and lactated ringer’s injection, usp is contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream). in patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including lactated ringer’s injection, usp, through the same infusion line (e.g., via y-connector). if the same infusion line is used for sequential administration, the line must be thoroughly flushed between infusions with a compatible fluid. lactated ringer’s injection, usp is contraindicated in patients with a known hypersensitivity to sodium lactate.

United States - English - NLM (National Library of Medicine)

dechra veterinary products - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - sodium chloride 526 mg in 100 ml - veterinary phylyte® injection ph 7.4 (multiple electrolytes injection, type 1, usp) is indicated as a source of water and electrolytes or as an alkalinizing agent. veterinary phylyte® injection ph 7.4 (multiple electrolytes injection, type 1, usp) is compatible with blood or blood components. it may be administered prior to or following the infusion of blood through the same administration set (i.e. as a priming solution), added to or infused concurrently with blood components, or used as a diluent in the transfusion of packed erythrocytes. veterinary phylyte® injection ph 7.4 (multiple electrolytes injection, type 1, usp) and 0.9% sodium chloride injection, usp are equally compatible with blood or blood components. none known.

United States - English - NLM (National Library of Medicine)

sypharma pty ltd - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37) - sodium chloride 600 mg in 100 ml - sykes electrolyte solution compound sodium lactate (hartmann’s solution) is indicated as a source of water and electrolytes for all species. it is also used as an alkalinizing agent. sykes electrolyte solution compound sodium lactate (hartmann’s solution) is contraindicated in patients with a known hypersensitivity to sodium lactate; congestive heart failure or severe impairment of renal function; clinical states in which the administration of sodium and chloride is detrimental.